Trademark Search  /  ZELLERX

ZELLERX

○ Dead · Abandoned

U.S. federal trademark · Serial No. 78251079

Mark
ZELLERX
Status
Abandoned
Serial Number
78251079
Filing Date
May 16, 2003
Class(es)
Class 001, Class 005, Class 009, Class 016, Class 041

Owners

ZelleRx Corporation
03 · Chicago, IL, US
ZelleRx Corporation
03 · Chicago, IL, US

Goods & Services

EQUIPMENT FOR LABORATORIES AND RESEARCH ESTABLISHMENTS, NAMELY, DISPOSABLE, STERILIZED TRAYS FOR THE STORAGE AND TRANSFER OF CELLULAR PRODUCTS FOR SCIENTIFIC, LABORATORY OR MEDICAL RESEARCH, THE MANUFACTURE OF PHARMACEUTICALS, AND CLINICAL USE; AND COMPUTER SOFTWARE FOR LABORATORIES, SCIENTISTS AND OTHERS CONDUCTING RESEARCH, DEVELOPMENT, AND QUALITY ASSURANCE FOR PRODUCTS IN PROCESS AND FINAL PRODUCT RELEASE, TO DETERMINE THE COMPONENTS AND QUALITY OF BIOLOGICALS

CELLS, CELL EXTRACTS AND GENETICALLY ALTERED CELL EXTRACTS FOR SCIENTIFIC, LABORATORY OR MEDICAL RESEARCH, AND FOR THE MANUFACTURE OF PHARMACEUTICALS; CELL CULTURE MEDIA AND ADDITIVES FOR SCIENTIFIC, LABORATORY OR MEDICAL RESEARCH, AND FOR THE MANUFACTURE OF PHARMACEUTICALS

Printed publications, namely, articles, pamphlets, workbooks, notebooks, newsletters and magazines concerning scientific, laboratory or medical research, the manufacture of pharmaceuticals, and clinical use of pharmaceuticals

Educational services, namely programs, seminars, workshops and conferences concerning scientific, laboratory or medical research, the manufacture of pharmaceuticals, and clinical use of pharmaceuticals

PHARMACEUTICALS, NAMELY, CELLS, CELL EXTRACTS AND GENETICALLY ALTERED CELL EXTRACTS FOR THE TREATMENT OF CANCER AND FOR MEDICAL AND CLINICAL USE; AND CELL CULTURE MEDIA AND ADDITIVES FOR CLINICAL USE

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "ZELLERX" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.